Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

Although venous thromboembolism (VTE) is quite common in patients suffering from different stages of cancer, it is still an underestimated problem. Oncological treatment, surgeries, and advanced-stage cancer are only some risk factors for VTE, which is one of the most common causes of death in cancer patients. Differences in the risk of deep-venous thrombosis and its complications, including risk of bleeding, between particular onco­logical patient groups suggests that there is a need for individual risk assessment and prophylaxis dedicated to specific clinical situations and patients. They also give grounds for constant update of guidelines on prophylaxis in cancer patients. This document contains venous thromboembolism prophylaxis guidelines in oncology patients with focus on surgical cancer.

• Publication year

  2017

• Venue

  Acta Angiologica

• Publication date

  2017-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.5603/AA.2016.0011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Parenteral anticoagulation in ambulatory patients with cancer.

  2017cited by this paper
• Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patients.

  2017cited by this paper
• Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases.

  2016cited by this paper
• VTE risk assessment in cancer

  2016cited by this paper
• Association between postoperative thromboembolism prophylaxis and complications following urological surgery.

  2016cited by this paper
• Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy

  2016cited by this paper
• [Venous thromboembolism in multiple myeloma].

  2016cited by this paper
• Incidence of Venous Thromboembolism After Oral Oncologic Surgery With Simultaneous Reconstruction.

  2016cited by this paper
• Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer.

  2016cited by this paper
• Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery.

  2015cited by this paper
• Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.

  2015cited by this paper
• Guideline on aspects of cancer‐related venous thrombosis

  2015cited by this paper
• Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.

  2015cited by this paper
• Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England

  2015cited by this paper
• Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery.

  2015cited by this paper
• Safety and Efficacy of Fondaparinux for Prophylaxis of Venous Thromboembolism after Colorectal Cancer Resection: A Propensity Score Matched Analysis

  2015cited by this paper
• Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.

  2015cited by this paper
• The risk of venous thromboembolism in ENT and head & neck surgery.

  2015cited by this paper
• A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors

  2015cited by this paper
• Incidence of symptomatic venous thromboembolism in oncological oral and maxillofacial operations: retrospective analysis.

  2015cited by this paper
• Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers

  2015cited by this paper
• Venous thrombosis in patients with high-grade glioma

  2015cited by this paper
• Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.

  2015cited by this paper
• Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period.

  2015cited by this paper
• Venous thromboembolism and lung cancer: a review

  2015cited by this paper
• Venous thromboembolism (VTE) and glioblastoma

  2015cited by this paper
• Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy

  2015cited by this paper
• Predictors of Venous Thromboembolism after Colorectal Surgery in a Single Unit

  2015cited by this paper
• Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.

  2015cited by this paper
• Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period.

  2015cited by this paper
• Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis.

  2015cited by this paper
• Diagnosis of VTE postdischarge for major abdominal and pelvic oncologic surgery: implications for a change in practice.

  2015cited by this paper
• Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology

  2014cited by this paper
• Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma.

  2014cited by this paper
• Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH

  2014cited by this paper
• ESC Guidelines on the diagnosis and management of acute pulmonary embolism

  2014cited by this paper
• Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?

  2014cited by this paper
• Risk of postoperative deep venous thrombosis in patients with colorectal cancer treated with open or laparoscopic colorectal surgery: a meta-analysis.

  2014cited by this paper
• Burden and timing of venothrombolic events in patients younger than 65 years undergoing radical cystectomy for bladder cancer.

  2014cited by this paper
• Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH

  2014cited by this paper
• Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease

  2014cited by this paper
• Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies – systematic review and meta-analysis

  2014cited by this paper
• Increased risk of preoperative venous thromboembolism in patients with renal cell carcinoma and tumor thrombus

  2014cited by this paper
• The value of extended preoperative thromboprophylaxis with dalteparin in patients with ovarian cancer qualified to surgical treatment.

  2014cited by this paper
• Incidence of postoperative deep vein thrombosis after robotic-assisted laparoscopic prostatectomy: a prospective study in Chinese patients

  2014cited by this paper
• A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer

  2014cited by this paper
• Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

  2014cited by this paper
• Meta‐analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery

  2014cited by this paper
• Perioperative venous thromboembolism in patients with gynecological malignancies: a lesson from four years of recent clinical experience.

  2014cited by this paper
• Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations.

  2014cited by this paper
• Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period

  2014cited by this paper
• Venous thromboembolism in patients undergoing operations for lung cancer: a systematic review.

  2014cited by this paper
• ガイドライン解説 Venous thromboembolism prophylaxis and treatment in patients with cancer : American Society of Clinical Oncology clinical practice guideline update

  2014cited by this paper
• Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxis.

  2014cited by this paper
• The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus

  2014cited by this paper
• Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England

  2014cited by this paper
• Prevalence and associations of VTE in patients with newly diagnosed lung cancer.

  2014cited by this paper
• Cancer-Associated Thrombosis: An Overview

  2014influential reference
• Optimal Prophylactic Method of Venous Thromboembolism for Gastrectomy in Korean Patients: An Interim Analysis of Prospective Randomized Trial

  2014cited by this paper
• The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer

  2014cited by this paper
• Prevalence of venous thromboembolism in elective thoracic surgery.

  2013cited by this paper
• Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review

  2013influential reference
• [Effect of intermittent pneumatic compression on coagulation function and deep venous hemodynamics of lower limbs after rectal cancer resection].

  2013cited by this paper
• Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

  2013influential reference
• Does Heparin Prophylaxis Reduce the Risk of Venous Thromboembolism in Patients Undergoing Robot-Assisted Prostatectomy?

  2013cited by this paper
• Impact of chemotherapy on activated protein C‐dependent thrombin generation—Association with VTE occurrence

  2013cited by this paper
• Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients.

  2013cited by this paper
• Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2013cited by this paper
• Epidemiology of cancer-associated venous thrombosis.

  2013cited by this paper
• Prevention and treatment of venous thromboembolism--International Consensus Statement.

  2013cited by this paper
• Risk factors associated with venous thromboembolism in 49,028 mastectomy patients.

  2013cited by this paper
• International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

  2013cited by this paper
• Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2013cited by this paper
• The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.

  2013cited by this paper
• International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

  2013influential reference
• The Role of Cryosurgery of the Prostate for Nonsurgical Candidates

  2013cited by this paper
• Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.

  2013cited by this paper
• Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer

  2012cited by this paper
• Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012influential reference
• Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high‐risk neurosurgical patients

  2012cited by this paper
• Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer.

  2012cited by this paper
• Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Balancing Venous Thromboembolism and Hematoma After Breast Surgery

  2012cited by this paper
• Prevention of Venous Thromboembolic Events After Gynecologic Surgery

  2012cited by this paper
• Validation of a venous thromboembolism risk assessment model in gynecologic oncology.

  2012cited by this paper
• Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2012cited by this paper
• Anticancer treatment and thrombosis.

  2012cited by this paper
• Venous Thromboembolism Prophylaxis in Cancer Patients

  2012cited by this paper
• Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients

  2012cited by this paper
• [Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update].

  2012influential reference
• Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Post-Discharge Venous Thromboembolism After Cancer Surgery: Extending the Case for Extended Prophylaxis

  2011cited by this paper
• Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.

  2011cited by this paper
• Heparin prophylaxis and the risk of venous thromboembolism after robotic‐assisted laparoscopic prostatectomy

  2011cited by this paper
• Anticoagulation for patients with cancer and central venous catheters.

  2011cited by this paper
• Incidence and timing of venous thromboembolism after surgery for gynecological cancer.

  2011cited by this paper
• Risk factors for pelvic lymphoceles post‐radical prostatectomy

  2011cited by this paper
• Rates of Venous Thromboembolism Among Patients with Major Surgery for Cancer

  2011cited by this paper
• Profilaktyka i leczenie żylnej choroby zakrzepowo-zatorowej: „Konsensus Polski” — aktualizacja 2011

  2011cited by this paper
• Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.

  2011cited by this paper

• Mechanical methods of venous thromboembolism prevention: from guidelines to clinical practice.

  2019cites this paper
• A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making

  2018cites this paper